Most Clozapine Prescribers Satisfied With REMS Program

You May Be Interested In:A roller coaster of a day: The highs and lows of NCAA gymnastics semifinals



(MedPage Today) — Most physician prescribers were satisfied with the FDA’s controversial risk evaluation and mitigation strategy (REMS) program for clozapine, survey data showed.
Among 196 doctors who prescribed clozapine, 64% said the positive…

share Paylaş facebook pinterest whatsapp x print

Similar Content

Publisher’s Platform: Senators step up to help save FDA funding of state inspection programs
Lung Cancer Screening Rates Nearly 4 Times Lower Than Breast, Colon Cancers
Lung Cancer Screening Rates Nearly 4 Times Lower Than Breast, Colon Cancers
Lower LDL of ‘Critical Importance’ in Reducing Dementia Risk
Lower LDL of ‘Critical Importance’ in Reducing Dementia Risk
Cyberattack roundup: Ransomware hits Georgia hospital and Colorado pathology services
Cyberattack roundup: Ransomware hits Georgia hospital and Colorado pathology services
A photo of two voters — a man in the back and a woman with a baby carrier in the front.
Many Voters Backed Abortion Rights and Donald Trump, a Challenge for Democrats – KFF Health News
Trump Picks New York Rep. Elise Stefanik as Ambassador to UN
Trump Picks New York Rep. Elise Stefanik as Ambassador to UN
Today's Insight | © 2025 | News